External resources NEJM: Triple Hormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial PMC: Retatrutide - A Game Changer in Obesity Pharmacotherapy PMC: Efficacy and Safety of Retatrutide - Systematic Review and Meta-Analysis American Diabetes Association: Retatrutide Clinical Highlights Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, personalized dosing tools, and a community of thousands who have navigated these exact decisions
Withdrawing a smaller or larger aliquot changes the absolute mass of every component simultaneously, but the ratio between them stays locked at 5:1:1:1
GLP-1s are intended to be utilized alongside healthy lifestyle changes, and without them can leave an individual vulnerable to reverting once they cease GLP-1 treatment (e.g., after one to two years due to side effects)
Clean the injection area properly before use
Adjustments may be made based on how the patient tolerates the medication, their appetite, or doctor recommendations
In comparison to treatment with 3.0 mg of liraglutide, the treatment group administered a 4.5 mg dose of cagrilintide experienced a greater reduction in weight loss by 1.8%